A Clinical Study to Evaluate JSP191 for the Treatment of Severe Autoimmune Disease
Latest Information Update: 26 May 2021
At a glance
- Drugs Briquilimab (Primary)
- Indications Autoimmune disorders
- Focus Therapeutic Use
- 26 May 2021 New trial record
- 19 May 2021 According to a Jasper Therapeutics media release, Jasper Therapeutics in partnership with the NIH will start enrollment for this trial in 2021.